![]() ![]() Cost will remain constant with availability of the Generation 2 product (5500/200 mg vial 27 500 for low dose 49 500 for high dose). In our online survey, 66 of hospitals who had not yet added andexanet alfa to formulary cited cost as a reason. Low titers of anti-ANDEXXA antibodies were observed in 26/145 healthy subjects (17) 6 (9/145) were first observed at Day 30 with 20 subjects (14. Speakers included Kelly McNeil-Posey, director of health economics and outcomes research at Alexion and Sharon Williams, director of U.S. Andexanet alfa poses a notable financial challenge for hospitals. Using an electrochemiluminescence (ECL)-based assay, 145 ANDEXXA-treated healthy subjects were tested for antibodies to ANDEXXA as well as antibodies cross-reacting with Factor X (FX) and FXa. Use a 20-mL (or larger) syringe and 20-gauge (or higher) needle. The panel discussion detailed an approved model structure developed with clinical guidance on the cost-effectiveness and budgetary impact of andexanet alfa on selected health outcomes and costs. 200 mg vials: Reconstitute the 200 mg vial of Andexxa with 20 mL of Sterile Water for Injection (SWFI). webinar “Andexanet alfa Budget Impact Model” originally broadcast on May 26 has been posted online. The DFW Hospital Council (DFWHC) and Alexion Pharmaceuticals, Inc. ![]()
0 Comments
Leave a Reply. |